Biotia, founded at the Jacobs Technion-Cornell Institute Runway Startup Postdoc Program, announced a $2.4 million seed round led by Falcon III Ventures.
Biotia is a health tech company that leverages next-generation DNA sequencing (NGS) and artificial intelligence (AI) software to help hospitals detect and diagnose infectious diseases.
According to a release issued by the company, “The funds will be used to further develop and implement Biotia’s diagnostic testing methods, including its AI-based software Chelsea™, offer myriad advantages over the current approaches in hospitals, such as limited PCR panels or culturing.”
Media Highlights
City & State NY
The 2021 Construction Power 50Bloomberg Opinion
How Eric Adams Would Run New YorkSan Antonio Express-News
Jefferson: Rackspace co-founder Graham Weston wants progress, and he wants it nowRELATED STORIES

New Cornell Tech Course Helping Cities Reboot
By Melanie Lefkowitz A platform that uses machine learning, sensors and location data …

Auggi Acquired by Seed Health
Cornell Tech alumni startup Auggi was recently acquired by Seed Health, a …

Runway Q&A: AwareHealth
AwareHealth, a Runway Startup at the Jacobs Technion-Cornell Institute, is a fully …